Plan B One-Step 1.5 mg Oral Tablet
RxNorm 858079
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 858079 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Plan B One-Step 1.5 mg Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBDPrescribable
Semantic Branded Drug (SBD):
Levonorgestrel 1.5 mg Oral Tablet [Plan B One-Step]
(Atom ID: 12358858)
PSNPrescribable
Prescribable Name (PSN):
Plan B One-Step 1.5 mg Oral Tablet
(Atom ID: 6372003)
SYPrescribable
Synonym (SY):
Plan B One-Step 1.5 mg Oral Tablet
(Atom ID: 2983574)
Patient Education
Levonorgestrel
Levonorgestrel is used to prevent pregnancy after unprotected sexual intercourse (sex without any method of birth control or with a birth control method that failed or was not used properly [e.g., a condom that slipped or broke or birth control pills that were not taken as scheduled]). Levonorgestrel should not be used to prevent pregnancy on a regular basis. This medication is to be used as an emergency contraceptive or backup in case regular birth control fails or is used incorrectly. Levonorgestrel is in a class of medications called progestins. It works by preventing the release of an egg from the ovary or preventing fertilization of the egg by sperm (male reproductive cells). It also may work by changing the lining of the uterus (womb) to prevent development of a pregnancy. Levonorgestrel may prevent pregnancy, but it will not prevent the spread of human immunodeficiency virus (HIV, the virus that causes acquired immunodeficiency syndrome [AIDS]) and other sexually transmitted diseases.
[Learn More]
* Please review the disclaimer below.